相关实验视频

Updated: Sep 19, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

一种对谷氨敏感的铁性诱导剂,具有较高的可变铁池和自供应的过氧化物,用于化学动力学治疗

Penghui Wei^1,2,3, Xuegang Niu^1,2,3, Dengliang Wang^1,2,3

¹Department of Neurosurgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 35005, China.

Materials today. Bio

|June 16, 2025

概括

这项研究引入了新的纳米粒子,通过在瘤细胞中释放铁和过氧化物来增强化学动力学治疗 (CDT). 这种方法增强了氧化应激,并触发了铁化,以有效治疗癌症.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗癌症治疗

背景情况:

化学动力学疗法 (CDT) 使用铁素 (Fe2+) 进行芬顿反应,但铁通常以铁酸铁 (Fe3+) 形式储存在费里中,从而限制了疗效.
瘤微环境对基于铁的疗法构成挑战,原因是铁的储存和谷氨 (GSH) 的存在.

研究的目的:

开发用于增强化学动力学疗法 (CDT) 的氧化还原反应纳米粒子 (MO@DSSP NPs).
通过纳米粒子研究OSMI-1和甲基酸氧化 (MLH) 输送的协同效应.
探索增加细胞内可变铁池 (LIP) 和诱导铁亡的机制.

主要方法:

制备嵌入OSMI-1和MLH的氧化回应MO@DSSP纳米颗粒.
瘤细胞在缩小微环境中的纳米颗粒的内部化.
抑制费里重链 (FTH) O-GlcNAcylation以增加LIP.
诱导线粒体分裂,自和随后的铁亡.

主要成果:

MO@DSSPNP在瘤微环境中分解,释放OSMI-1和MLH,并消耗GSH.
抑制FTH O-GlcNAcylation增加了细胞内LIP和氧化应激.
机动化铁促进了基生成,脂质过氧化和铁.
这些纳米颗粒显示出在癌症治疗中临床应用的巨大潜力.

结论:

通过调动内源性铁和优化过氧化物供应,新型氧化回应纳米颗粒有效地增强化学动力疗法.
该策略抑制FTH O-GlcNAcylation,导致LIP增加和ferroptosis诱导.
这种方法为开发先进的癌症纳米药物提供了一个有希望的平台.

关键词:

化学动力学疗法是一种化学动力学疗法.费里丁重链蛋白质的使用.铁性化 (ferroptosis) 是一种不稳定的铁池池.这是一种O-GlcNAcylation.

更多相关视频

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research

Published on: June 28, 2024

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...